The ROE (Return on Equity) of Recursion Pharmaceuticals Inc (RXRX) is -44.81%.
ROE (Return on Equity) shows how effectively a company utilizes shareholders equity to produce earnings. It serves as a key indicator of financial return for investors.
| Date | Value |
|---|---|
| 2024-12-31 | -44.81% |
| 2023-12-31 | -70.79% |
| 2022-12-31 | -49.30% |
| 2021-12-31 | -34.35% |
| 2020-12-31 | -35.95% |
| 2019-12-31 | -80.57% |